Systemic therapy of liver cancer-Reference-Cited by-同舟云学术

Systemic therapy of liver cancer

Published:2021 Issue: Volume: Page:257-294
ISSN:0065-230X
Container-title:Advances in Cancer Research
language:
Short-container-title:

Author:

Demir Tarik,Lee Sunyoung S.,Kaseb Ahmed O.

Publisher

Elsevier

Reference112 articles.

1. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma;Abou-Alfa;The New England Journal of Medicine,2018

2. Assessment of treatment with sorafenib plus doxorubicin vs sorafenib alone in patients with advanced hepatocellular carcinoma: Phase 3 CALGB 80802 randomized clinical trial;Abou-Alfa;JAMA Oncology,2019

3. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: Data from the fibrolamellar carcinoma consortium;Ang;Gastrointestinal Cancer Research,2013

4. Progression after immunotherapy for fibrolamellar carcinoma;Bauer;Visceral Medicine,2019

5. Interferon-alpha up-regulates the expression of PD-L1 molecules on immune cells through STAT3 and p 38 signaling;Bazhin;Frontiers in Immunology,2018

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and efficacy evaluation of nanoliposomes targeting CAFs-LCSCs communication for hepatocellular carcinoma treatment;Chemical Engineering Journal;2024-09

2. Assessing TGF-β Prognostic Model Predictions for Chemotherapy Response and Oncogenic Role of FKBP1A in Liver Cancer;Current Pharmaceutical Design;2024-08-23

3. The immunotherapy mechanism of Hedyotis Diffusae Herba in treating liver cancer: a study based on network pharmacology, bioinformatics, and experimental validation;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-02

4. Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies;Cancer Letters;2024-08

5. Yadanziolide A Inhibits Proliferation and Induces Apoptosis of Hepatocellular Carcinoma via JAK-STAT Pathway: A Preclinical Study;Biology;2024-07-16